Trace and major elements in serum of patients with chronic myelogenous leukemia

被引：0

作者：

C. G. L. Canellas

S. M. F. Carvalho

E. F. O. De Jesus

M. J. Anjos

R. T. Lopes

机构：

[1] Federal University of Rio de Janeiro/COPPE,

[2] Nuclear Instrumentation Laboratory,undefined

[3] Foundation Institute of Hematology,undefined

[4] Federal University of Rio de Janeiro/COPPE,undefined

[5] Nuclear Instrumentation Laboratory; Physics Institute,undefined

[6] UERJ,undefined

[7] Federal University of Rio de Janeiro/COPPE,undefined

[8] Nuclear Instrumentation Laboratory; Physics Institute,undefined

[9] UERJ,undefined

[10] Federal University of Rio de Janeiro/COPPE,undefined

[11] Nuclear Instrumentation Laboratory,undefined

来源：

Journal of Radioanalytical and Nuclear Chemistry | 2006年 / 269卷

关键词：

Healthy Subject; Serum Sample; Elemental Concentration; Major Element; Chronic Myelogenous Leukemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Major and trace elements were determined in serum of patients with chronic myelogenous leukemia (CML) using total reflection X-ray fluorescence induced by synchrotron radiation (SRTXRF). CML affects 1 to 2 people per 100,000 and accounts for 7-20% cases of leukemia. It was possible to determine the concentrations of the following elements: P, S, Cl, K, Ca, Cr, Mn, Fe, Ni, Cu, Zn, Br and Rb. Using analysis of variance (ANOVA) it was observed that the contents of the P, S, Ca, Cr, Mn, Fe, Cu and Rb elements differed significantly at a = 0.05 between groups of healthy subjects and CML patients and also genders (males and females).

引用

页码：631 / 634

页数：3

共 50 条

[11] BASOPHIL FUNCTION IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
LETTBROWN, MA
JUNEJA, HS
BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (04) : 621 - 626
[12] HLA genes in patients with chronic myelogenous leukemia
Khamaganova, E.
Zaretskaya, Y.
Ledniov, Y.
TISSUE ANTIGENS, 2008, 71 (04): : 332 - 332
[13] Methylation profile in patients with chronic myelogenous leukemia
Marinitch, D.
Volcovets, N. D.
Tsvirko, D. G.
Buryanov, Y. L.
Shevtchuk, T. V.
Dyachenkoz, O. V.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 58 - 58
[14] SERUM AND URINARY PROTEINS AND RENAL FUNCTION IN CHRONIC MYELOGENOUS LEUKEMIA
PRUZANSKI, W
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1972, 263 (03): : 163 - +
[15] AN EXPERIMENTAL-STUDY OF SERUM INTERFERONS IN CHRONIC MYELOGENOUS LEUKEMIA
TSUCHIKAWA, K
SATO, I
SUZUKI, C
WATANABE, Y
ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (03): : 589 - 597
[16] CRKL IS THE MAJOR TYROSINE-PHOSPHORYLATED PROTEIN IN NEUTROPHILS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
HEANEY, C
ODA, T
HAGOPIAN, JR
OKUDA, K
GRIFFIN, JD
DRUKER, BJ
BLOOD, 1994, 84 (10) : A381 - A381
[17] CRKL IS THE MAJOR TYROSINE-PHOSPHORYLATED PROTEIN IN NEUTROPHILS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA
ODA, T
HEANEY, C
HAGOPIAN, JR
OKUDA, K
GRIFFIN, JD
DRUKER, BJ
JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (37) : 22925 - 22928
[18] CHRONIC MYELOGENOUS LEUKEMIA
不详
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1954, 155 (03): : 323 - 323
[19] Chronic myelogenous leukemia
Mauro, MJ
Druker, BJ
CURRENT OPINION IN ONCOLOGY, 2001, 13 (01) : 3 - 7
[20] Optimizing Therapy for Patients With Chronic Myelogenous Leukemia in Chronic Phase
Kantarjian, Hagop M.
Cortes, Jorge
La Rosee, Paul
Hochhaus, Andreas
CANCER, 2010, 116 (06) : 1419 - 1430

← 1 2 3 4 5 →